Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010
RSC Advances · 2025 · 15 (58) · 50392-50407
DOI: 10.1039/d5ra07858j ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Advances, 2025. Verfasst von Xue Tang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Provincial Key Laboratory of Quality and Innovation Research of Chinese Materia Medica, Sichuan Academy of Chinese Medicine Sciences Chengdu …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Indirubin, an active component of the traditional Chinese medicine Indigo Naturalis, has drawn significant attention owing to its remarkable anti-leukemia activity.
Autor:innen und Institutionen
- Sichuan Provincial Key Laboratory of Quality and Innovation Research of Chinese Materia Medica, Sichuan Academy of Chinese Medicine Sciences Chengdu 610041 P. R. China chenchu1978@foxmail.com.
- Department of Pharmacy, Chengdu Eighth People's Hospital, Geriatric Hospital of Chengdu Medical College Chengdu Sichuan 610083 P. R. China.
- Department of Pharmacy, The Thirteenth People's Hospital of Chongqing, Chongqing Geriatrics Hospital Chongqing 400053 P. R. China lyq82893@163.com.
ORCID-Profile: Xue Tang, Yan-Qing Liu
Förderung
- Science and Technology Department of Sichuan Province
Zitieren
APA
Tang, X., Luo, Q. Q., Li, B., Wu, Y., Liu, Y. Q., & Chen, C. (2025). Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010. RSC Advances, 15(58), 50392-50407. https://doi.org/10.1039/d5ra07858j
Vancouver
Tang X, Luo QQ, Li B, Wu Y, Liu YQ, Chen C. Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010. RSC Advances. 2025;15(58):50392-50407. doi:10.1039/d5ra07858j
BibTeX
@article{Tang2025,
author = {Tang, Xue and Luo, Qing-Qing and Li, Bin and Wu, Yan and Liu, Yan-Qing and Chen, Chu},
title = {Synthetic progress and anti-leukemic research on indirubin analogues: a review since 2010},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {58},
pages = {50392--50407},
doi = {10.1039/d5ra07858j}
}
EUVIMED